• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“三合一奇迹”:改良机器人辅助经口甲状腺切除术的回顾性队列研究

"Three-in-One Wonder": A Retrospective Cohort Study on Modified Robotic-Assisted Transoral Thyroidectomy.

作者信息

Wen Xiaoyong, Zhou Shiwei, Wu Peng, Li Wu, Li Hui, Wang Zhiyuan, Zhang Lu, Li Jigang, Peng Xiaowei

机构信息

Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, P. R. China.

Department of Thyroid Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.

出版信息

J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241304384. doi: 10.1177/19160216241304384.

DOI:10.1177/19160216241304384
PMID:39716478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672377/
Abstract

IMPORTANCE

With advancements in robotic surgery, robotic-assisted thyroidectomy is gaining popularity. The introduction of the 3-port transoral robotic thyroidectomy (T-TORT) offers an alternative approach with potential benefits in postoperative recovery compared to traditional methods.

OBJECTIVE

To assess the safety and feasibility of T-TORT in comparison to the transoral endoscopic thyroidectomy vestibular approach (TOETVA).

DESIGN

A retrospective cohort study with 1:1 propensity score matching was conducted to compare perioperative outcomes between T-TORT and TOETVA. The learning curve was analyzed using cumulative summation (CUSUM).

SETTING

Tertiary A hospital.

PARTICIPANTS

One hundred sixty-two patients who underwent either T-TORT or TOETVA were included.

INTERVENTION OR EXPOSURES

The T-TORT group underwent three-port robotic thyroidectomy, while the TOETVA group received standard transoral vestibular endoscopic thyroidectomy.

MAIN OUTCOMES AND MEASURES

Demographics and perioperative data were compared. The learning curve was evaluated using CUSUM.

RESULTS

Compared with the TOETVA group the operation time in minutes of the T-TORT group was relatively longer (136.14 ± 36.52 vs 122.49 ± 34.85,  = .012), the postoperative stay, in days, was shorter (2.77 ± 0.78 vs 3.51 ± 0.95,  < .001), the drainage volume on a postoperative day 1 (POD1) and POD2, in milliliter, was less (POD1 56.57 ± 23.29 vs 65.12 ± 26.04,  = .029 and POD2 27.43 ± 25.29 vs 38.21 ± 25.09,  = .008). The other statistics, including bleeding amount, retrieved and metastatic central lymph nodes, visual analog scale score, and drainage volume on an operative day were comparable between the 2 groups. Meanwhile, there were no significant differences between the 2 groups in postoperative complication rates. The turning point of the learning curve was in the 16th case with a hemithyroidectomy with central neck dissection (CND) and the 21st case with a bilateral thyroidectomy with CND.

CONCLUSIONS AND RELEVANCE

T-TORT is a safe and feasible option with enhanced postoperative recovery compared to TOETVA. It may be a preferable choice in specific clinical situations.

TRIAL REGISTRATION

This study was registered at the Chinese Clinical Trial Registry (UIN: ChiCTR2300069021, https://www.chictr.org.cn) in accordance with the World Medical Association's Declaration of Helsinki, 2013.

摘要

重要性

随着机器人手术技术的进步,机器人辅助甲状腺切除术越来越受欢迎。三孔经口机器人甲状腺切除术(T-TORT)的引入提供了一种替代方法,与传统方法相比,在术后恢复方面具有潜在优势。

目的

评估T-TORT与经口内镜甲状腺切除术前庭入路(TOETVA)相比的安全性和可行性。

设计

采用倾向评分1:1匹配的回顾性队列研究,比较T-TORT和TOETVA的围手术期结局。使用累积求和(CUSUM)分析学习曲线。

地点

三级甲等医院。

参与者

纳入162例行T-TORT或TOETVA的患者。

干预或暴露

T-TORT组接受三孔机器人甲状腺切除术,而TOETVA组接受标准经口前庭内镜甲状腺切除术。

主要结局和测量指标

比较人口统计学和围手术期数据。使用CUSUM评估学习曲线。

结果

与TOETVA组相比,T-TORT组的手术时间(分钟)相对较长(136.14±36.52 vs 122.49±34.85,P = 0.012),术后住院天数较短(2.77±0.78 vs 3.51±0.95,P < 0.001),术后第1天(POD1)和第2天的引流量(毫升)较少(POD1 56.57±23.29 vs 65.12±26.04,P = 0.029;POD2 27.43±25.29 vs 38.21±25.09,P = 0.008)。其他统计数据,包括出血量、中央区淋巴结清扫数量和转移情况、视觉模拟评分以及手术日引流量,两组之间具有可比性。同时,两组术后并发症发生率无显著差异。学习曲线的转折点分别为第16例单侧甲状腺切除加中央区淋巴结清扫(CND)和第21例双侧甲状腺切除加CND。

结论及相关性

与TOETVA相比,T-TORT是一种安全可行的选择,术后恢复更好。在特定临床情况下可能是更优选择。

试验注册

本研究已按照2013年世界医学协会《赫尔辛基宣言》在中国临床试验注册中心注册(注册号:ChiCTR2300069021,https://www.chictr.org.cn)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/b7f63318fb7f/10.1177_19160216241304384-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/285835d66275/10.1177_19160216241304384-img2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/0c1294df244e/10.1177_19160216241304384-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/ea563008470e/10.1177_19160216241304384-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/b7f63318fb7f/10.1177_19160216241304384-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/285835d66275/10.1177_19160216241304384-img2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/0c1294df244e/10.1177_19160216241304384-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/ea563008470e/10.1177_19160216241304384-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f724/11672377/b7f63318fb7f/10.1177_19160216241304384-fig3.jpg

相似文献

1
"Three-in-One Wonder": A Retrospective Cohort Study on Modified Robotic-Assisted Transoral Thyroidectomy.“三合一奇迹”:改良机器人辅助经口甲状腺切除术的回顾性队列研究
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241304384. doi: 10.1177/19160216241304384.
2
Defining the Thyroid-RLN Entry Triangle for Enhanced Recurrent Laryngeal Nerve Exposure in TOETVA: A Retrospective Study.定义甲状腺-喉返神经入路三角以增强全乳晕入路腔镜甲状腺手术中喉返神经的显露:一项回顾性研究
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241301328. doi: 10.1177/19160216241301328.
3
Transoral robotic thyroidectomy versus transoral endoscopic thyroidectomy: a propensity-score-matched analysis of surgical outcomes.经口机器人甲状腺切除术与经口内镜甲状腺切除术:手术结果的倾向评分匹配分析
Surg Endosc. 2021 Nov;35(11):6179-6189. doi: 10.1007/s00464-020-08114-1. Epub 2020 Oct 27.
4
Comparative surgical outcomes of transoral endoscopic and robotic thyroidectomy for thyroid carcinoma: a propensity score-matched analysis.经口内镜与机器人甲状腺癌切除术的手术疗效比较:倾向评分匹配分析
Surg Endosc. 2023 Feb;37(2):1132-1139. doi: 10.1007/s00464-022-09636-6. Epub 2022 Sep 21.
5
Comparison Study of Robotic Thyroidectomies Through a Bilateral Axillo-Breast Approach and a Transoral Approach.经双侧腋窝-乳房入路与经口入路机器人甲状腺切除术的比较研究
J Laparoendosc Adv Surg Tech A. 2020 Feb;30(2):175-182. doi: 10.1089/lap.2019.0585. Epub 2019 Oct 30.
6
Transoral robotic thyroidectomy versus conventional open thyroidectomy: comparative analysis of surgical outcomes using propensity score matching.经口机器人甲状腺切除术与传统开放性甲状腺切除术:使用倾向评分匹配法对手术结果的比较分析
Surg Endosc. 2021 Jan;35(1):124-129. doi: 10.1007/s00464-020-07369-y. Epub 2020 Jan 10.
7
Transoral endoscopic and robotic thyroidectomy for thyroid cancer: the mid-term oncological outcome.经口内镜甲状腺切除术和机器人甲状腺切除术治疗甲状腺癌:中期肿瘤学结果。
Surg Endosc. 2023 Oct;37(10):7829-7838. doi: 10.1007/s00464-023-10339-9. Epub 2023 Aug 21.
8
Transoral endoscopic thyroidectomy vestibular approach vs. transoral robotic thyroidectomy: systematic review and meta-analysis.经口内镜甲状腺切除术前庭入路与经口机器人甲状腺切除术:系统评价和荟萃分析。
Updates Surg. 2023 Oct;75(7):1773-1781. doi: 10.1007/s13304-023-01623-3. Epub 2023 Aug 9.
9
[A retrospective comparative study between robotic thyroidectomy through transoral vestibular approach and bilateral breast-axillary approach].经口前庭入路与双侧乳晕腋窝入路机器人甲状腺切除术的回顾性对比研究
Zhonghua Wai Ke Za Zhi. 2023 Mar 1;61(3):227-231. doi: 10.3760/cma.j.cn112139-20220810-00348.
10
Comparison of surgical outcomes of transoral robotic and endoscopic thyroidectomy: A systematic review and network meta-analysis.经口机器人手术与内镜甲状腺手术的手术效果比较:一项系统评价与网状Meta分析
Head Neck. 2024 Mar;46(3):688-701. doi: 10.1002/hed.27644. Epub 2024 Jan 16.

本文引用的文献

1
Thyroglobulin Levels as a Predictor of Papillary Cancer Recurrence After Thyroid Lobectomy.甲状腺球蛋白水平作为甲状腺叶切除术后甲状腺癌复发的预测指标。
Anticancer Res. 2022 Nov;42(11):5619-5627. doi: 10.21873/anticanres.16070.
2
Comparative surgical outcomes of transoral endoscopic and robotic thyroidectomy for thyroid carcinoma: a propensity score-matched analysis.经口内镜与机器人甲状腺癌切除术的手术疗效比较:倾向评分匹配分析
Surg Endosc. 2023 Feb;37(2):1132-1139. doi: 10.1007/s00464-022-09636-6. Epub 2022 Sep 21.
3
Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis.
经口机器人甲状腺切除术治疗甲状腺肿瘤的安全性和有效性:一项系统评价和荟萃分析
Cancers (Basel). 2022 Aug 31;14(17):4230. doi: 10.3390/cancers14174230.
4
Learning curve of transoral robotic thyroidectomy.经口机器人甲状腺切除术的学习曲线。
Surg Endosc. 2023 Jan;37(1):535-543. doi: 10.1007/s00464-022-09549-4. Epub 2022 Aug 24.
5
The Advantages of Robotic Over Open Thyroidectomy in Thyroid Diseases: A Systematic Review.机器人甲状腺切除术与开放性甲状腺切除术治疗甲状腺疾病的优势:一项系统评价。
Cureus. 2022 Jun 25;14(6):e26320. doi: 10.7759/cureus.26320. eCollection 2022 Jun.
6
Prophylactic central lymph node dissection in differentiated thyroid cancer - benefits and risk.分化型甲状腺癌预防性中央区淋巴结清扫术——获益与风险。
Folia Med (Plovdiv). 2022 Jun 30;64(3):430-436. doi: 10.3897/folmed.64.e64030.
7
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology.外科肿瘤学中的术后加速康复(ERAS)。
Curr Oncol Rep. 2022 Sep;24(9):1177-1187. doi: 10.1007/s11912-022-01282-4. Epub 2022 Apr 11.
8
Comparison Between Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) and Conventional Open Thyroidectomy for Patients Undergoing Total Thyroidectomy and Central Neck Dissection: A Propensity Score-Matching Analysis.经口内镜甲状腺切除术前庭入路(TOETVA)与传统开放性甲状腺切除术治疗甲状腺全切除术及中央区颈淋巴结清扫术患者的比较:倾向评分匹配分析
Front Oncol. 2022 Mar 2;12:856021. doi: 10.3389/fonc.2022.856021. eCollection 2022.
9
Complications of Trans-oral Endoscopic Thyroidectomy Vestibular Approach: A Systematic Review.经口内镜甲状腺手术前庭入路的并发症:系统评价。
In Vivo. 2022 Jan-Feb;36(1):1-12. doi: 10.21873/invivo.12671.
10
Indications of Superselective Neck Dissection in Patients With Lateral Node Metastasis of Papillary Thyroid Carcinoma.甲状腺乳头状癌侧方淋巴结转移患者行超选择性颈清扫术的指征
Otolaryngol Head Neck Surg. 2022 May;166(5):832-839. doi: 10.1177/01945998211038318. Epub 2021 Sep 7.